Alucent Biomedical Funding & Investors

Alucent Biomedical is a biomedical company that develops a combination drug-device therapy called Natural Vascular Scaffolding (NVS) for the treatment of vascular diseases. NVS is a first-of-a-kind combination drug-device therapy designed to assist the body in naturally opening and maintaining arterial patency. The therapy focuses on peripheral artery disease (PAD), arteriovenous fistula (AVF) maturation for dialysis, and more.